Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC01425 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC00317 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927843 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00308 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC00320 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
D21S2088E - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101927869 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR548XHG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC339622 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMPRSS15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00158 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHODL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR155 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on